Lunai Bioworks Inc. (LNAI) — Financial statements
Income statement, balance sheet, and cash flow for Lunai Bioworks Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.13 | 0.00 | 0.00 | 0.00↓100.0% | 0.39 | |
| Gross Profit | -0.13 | 0.00 | 0.00 | 0.00↑100.0% | -0.39 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.54↓80.2% | 3↓35.0% | 4↓50.3% | 8↓46.1% | 16 | |
| General & Administrative Expenses | 18↓27.2% | 25↑60.3% | 15↑6.9% | 14 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 18↓27.2% | 25↑60.3% | 15↑6.9% | 14↑91.8% | 7 | |
| Other Expenses | 0.00↓100.0% | 54↑185.1% | 19↓79.6% | 93 | 0.00 | |
| Operating Expenses | 18↓77.4% | 82↑111.7% | 39↓66.8% | 116↑404.5% | 23 | |
| Total Costs & Expenses | 19↓77.3% | 82↑111.7% | 39↓66.8% | 116↑396.0% | 23 | |
| Operating Results | ||||||
| Operating Income | -19↑77.3% | -82↓111.7% | -39↑66.8% | -116↓396.0% | -23 | |
| Depreciation & Amortization | 0.13↑5.9% | 0.12↑7.4% | 0.11↓8.2% | 0.12↓68.4% | 0.39 | |
| EBITDA | -18↑78.6% | -86↓121.0% | -39↑65.6% | -113↓333.1% | -26 | |
| EBIT | -19↑78.4% | -86↓120.6% | -39↑65.5% | -113↓327.1% | -26 | |
| Interest & Other Income | ||||||
| Net Interest Income | -0.61↑75.0% | -2↓244.4% | -0.71↓181.9% | -0.25↑31.6% | -0.37 | |
| Interest Income | 0.12 | 0.00 | 0.00↓100.0% | 0.12↑826.0% | 0.01 | |
| Interest Expense | 0.73↓70.2% | 2↑244.4% | 0.71↑89.6% | 0.37↓1.8% | 0.38 | |
| Non-Operating Income | 0.00↓100.0% | 4↑935.6% | 0.42↑113.9% | -3↓198.4% | 3 | |
| Other Income / Expenses | -159↓2249.7% | -7↓502.1% | -1↓142.6% | 3↑176.8% | -3 | |
| Income Before Tax | -178↓101.3% | -88↓122.8% | -40↑65.0% | -113↓322.5% | -27 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00↓100.0% | 0.00↑100.0% | -0.13 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -178↓101.3% | -88↓122.8% | -40↑65.0% | -113↓324.5% | -27 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -178↓101.3% | -88↓122.8% | -40↑65.0% | -113↓324.5% | -27 | |
| Bottom-Line Net Income | -178↓101.3% | -88↓122.8% | -40↑65.0% | -113↓324.5% | -27 | |
| EPS (Basic) | -10.78↓18.5% | -9.10↓28.2% | -7.10↑67.1% | -21.60↓281.0% | -5.67 | |
| EPS (Diluted) | -10.78↓18.5% | -9.10↓28.2% | -7.10↑67.1% | -21.60↓281.0% | -5.67 | |
| Weighted Average Shares | 17↑69.3% | 10↑73.3% | 6↑7.1% | 5↑11.4% | 5 | |
| Weighted Average Diluted Shares | 17↑69.3% | 10↑73.3% | 6↑7.1% | 5↑11.4% | 5 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.